Bridge to Life Raises $110M to Expand Organ Perfusion
DULUTH, Georgia, August 12, 2026 Bridge to Life Ltd., a medical technology company specializing in organ preservation and perfusion...
FDA
Advertisement
Eli Lilly Escalates Fight Against Illegal Retatrutide Market
INDIANAPOLIS, Indiana, August 12, 2026 Eli Lilly and Company has intensified its efforts to combat the illegal sale of...
Annexon Expands Phase 3 ARCHER II Trial in Geographic Atrophy
BRISBANE, Calif., August 12, 202 Annexon, Inc. announced the expansion of its ongoing Phase 3 ARCHER II trial evaluating...
LeonaBio Advances Lasofoxifene in Metastatic Breast Cancer
BOTHELL, Wash., August 12, 2026 LeonaBio, Inc. announced that its lead investigational therapy lasofoxifene will be featured in multiple...
Can-Fite Advances Phase III Programs With FDA and EMA Status
RAMAT GAN, Israel, August 12, 2026 Can-Fite BioPharma Ltd. announced an update on the regulatory status of its two...
Advertisements
Innoviva Specialty Therapeutics Products Reach Galien Final
WALTHAM, Mass., August 11, 2026 Innoviva Specialty Therapeutics (IST) announced that three of its infectious disease therapies, XACDURO® (sulbactam/durlobactam),...
CalciMedica Advances Auxora and CM5480 in Pulmonary Hypertension
LA JOLLA, Calif., August 11, 2026 CalciMedica, Inc. reported its second-quarter 2026 financial results and provided updates across its...
AC Immune Receives FDA Fast Track Designation for ACI-7104 in Parkinson’s
LAUSANNE, Switzerland, August 11, 2026 AC Immune SA announced that the U.S. Food and Drug Administration (FDA) has granted...
FastWave Medical Gains FDA IDE Approval for Artero IVL
Minneapolis, Minnesota, August,11, 2026 FastWave Medical has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device...
EIT Pharma Gains FDA Acceptance for Lonafarnib NDA
Kirkland, Washington, August,11, 2026 EIT Pharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Advertisement
